Publications

Houghton PJ, Morton CL, Gorlick R, Kolb EA, Keir ST, Reynolds CP, Kang MH, Maris JM, Wu J, Smith MA,
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the pediatric preclinical testing program.
Pediatric blood & cancer.  2010 Feb 17.
PMID:20166202 [PubMed - as supplied by publisher]

Maris JM, Morton CL, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Reynolds CP, Kang MH, Wu J, Smith MA, Houghton PJ,
Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).
Pediatric blood & cancer.  2010 Jan 27.
PMID:20108338 [PubMed - as supplied by publisher]

Houghton PJ, Morton CL, Gorlick R, Lock RB, Carol H, Reynolds CP, Kang MH, Maris JM, Keir ST, Kolb EA, Wu J, Wozniak AW, Billups CA, Rubinstein L, Smith MA,
Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program.
Molecular cancer therapeutics.  2010 Jan.
PMID:20053767 [PubMed - in process]

Carol H, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Maris JM, Keir ST, Watkins A, Smith MA, Lock RB,
Initial testing of topotecan by the pediatric preclinical testing program.
Pediatric blood & cancer.  2010 May.
PMID:20017204 [PubMed - in process]

Smith MA, Morton CL, Kolb EA, Gorlick R, Keir ST, Carol H, Lock R, Kang MH, Reynolds CP, Maris JM, Watkins AE, Houghton PJ,
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing program.
Pediatric blood & cancer.  2010 Feb.
PMID:19856388 [PubMed - indexed for MEDLINE]

Gorlick R, Kolb EA, Houghton PJ, Morton CL, Phelps D, Schaiquevich P, Stewart C, Keir ST, Lock R, Carol H, Reynolds CP, Maris JM, Wu J, Smith MA,
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program.
Pediatric blood & cancer.  2009 Oct.
PMID:19554571 [PubMed - indexed for MEDLINE]

Carol H, Lock R, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Reynolds CP, Maris JM, Keir ST, Billups CA, Smith MA,
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Pediatric blood & cancer.  2009 Dec 15.
PMID:19554570 [PubMed - indexed for MEDLINE]

Keshelava N, Houghton PJ, Morton CL, Lock RB, Carol H, Keir ST, Maris JM, Reynolds CP, Gorlick R, Kolb EA, Wu J, Smith MA,
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program.
Pediatric blood & cancer.  2009 Sep.
PMID:19418547 [PubMed - indexed for MEDLINE]

Morton CL, Houghton PJ, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups C, Smith MA,
Initial testing of aplidin by the pediatric pre-clinical testing program.
Pediatric blood & cancer.  2009 Sep.
PMID:19418543 [PubMed - indexed for MEDLINE]

Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ,
Molecular characterization of the pediatric preclinical testing panel.
Clinical cancer research : an official journal of the American Association for Cancer Research.  2008 Jul 15.
PMID:18628472 [PubMed - indexed for MEDLINE]

Keir ST, Morton CL, Billups C, Smith MA, Houghton PJ, Gururangan S,
Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Sep.
PMID:18493996 [PubMed - indexed for MEDLINE]

Maris JM, Courtright J, Houghton PJ, Morton CL, Kolb EA, Lock R, Tajbakhsh M, Reynolds CP, Keir ST, Wu J, Smith MA,
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jul.
PMID:18293383 [PubMed - indexed for MEDLINE]

Smith MA, Morton CL, Phelps DA, Kolb EA, Lock R, Carol H, Reynolds CP, Maris JM, Keir ST, Wu J, Houghton PJ,
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jul.
PMID:18260120 [PubMed - indexed for MEDLINE]

Kolb EA, Gorlick R, Houghton PJ, Morton CL, Lock R, Carol H, Reynolds CP, Maris JM, Keir ST, Billups CA, Smith MA,
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jun.
PMID:18260118 [PubMed - indexed for MEDLINE]

Lock R, Carol H, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Reynolds CP, Maris JM, Keir ST, Wu J, Smith MA,
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jun.
PMID:18085673 [PubMed - indexed for MEDLINE]

Kolb EA, Gorlick R, Houghton PJ, Morton CL, Lock RB, Tajbakhsh M, Reynolds CP, Maris JM, Keir ST, Billups CA, Smith MA,
Initial testing of dasatinib by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jun.
PMID:17914733 [PubMed - indexed for MEDLINE]

Houghton PJ, Morton CL, Kolb EA, Gorlick R, Lock R, Carol H, Reynolds CP, Maris JM, Keir ST, Billups CA, Smith MA,
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Apr.
PMID:17635004 [PubMed - indexed for MEDLINE]

Tajbakhsh M, Houghton PJ, Morton CL, Kolb EA, Gorlick R, Maris JM, Keir ST, Wu J, Reynolds CP, Smith MA, Lock RB,
Initial testing of cisplatin by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 May.
PMID:17554786 [PubMed - indexed for MEDLINE]

Maris JM, Courtright J, Houghton PJ, Morton CL, Gorlick R, Kolb EA, Lock R, Tajbakhsh M, Reynolds CP, Keir ST, Wu J, Smith MA,
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Mar.
PMID:17457854 [PubMed - indexed for MEDLINE]

Houghton PJ, Morton CL, Kolb EA, Lock R, Carol H, Reynolds CP, Keshelava N, Maris JM, Keir ST, Wu J, Smith MA,
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program.
Pediatric blood & cancer.  2008 Jan.
PMID:17420992 [PubMed - indexed for MEDLINE]